Healthcare provider profile · identity verified

Nancy Sabal, D.O.

Family Practice · WYANDOTTE, MI · NPI 1801862248

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	581	162
Losartan Potassium	Losartan Potassium	439	112
Alprazolam	Alprazolam	409	82
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	382	51
Metformin Hcl	Metformin Hcl	334	96
Levothyroxine Sodium	Levothyroxine Sodium	332	92
Lisinopril	Lisinopril	310	93
Omeprazole	Omeprazole	250	80
Metoprolol Succinate	Metoprolol Succinate	238	64
Amlodipine Besylate	Amlodipine Besylate	237	73
Metoprolol Tartrate	Metoprolol Tartrate	237	60
Pantoprazole Sodium	Pantoprazole Sodium	206	65
Simvastatin	Simvastatin	173	51
Zolpidem Tartrate	Zolpidem Tartrate	166	34
Gabapentin	Gabapentin	153	41
Hydrochlorothiazide	Hydrochlorothiazide	149	44
Sertraline Hcl	Sertraline Hcl	147	39
Ibuprofen	Ibuprofen	137	43
Eliquis	Apixaban	121	27
Albuterol Sulfate Hfa	Albuterol Sulfate	120	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	118	34
Atenolol	Atenolol	110	29
Tramadol Hcl	Tramadol Hcl	110	24
Rosuvastatin Calcium	Rosuvastatin Calcium	108	33
Clonazepam	Clonazepam	98	17
Acetaminophen-Codeine	Acetaminophen With Codeine	93	19
Furosemide	Furosemide	93	35
Jardiance	Empagliflozin	91	22
Tamsulosin Hcl	Tamsulosin Hcl	91	24
Fluticasone Propionate	Fluticasone Propionate	90	23
Chlorthalidone	Chlorthalidone	88	24
Meloxicam	Meloxicam	80	25
Potassium Chloride	Potassium Chloride	77	28
Pravastatin Sodium	Pravastatin Sodium	77	21
Allopurinol	Allopurinol	74	20
Amoxicillin	Amoxicillin	74	64
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	19
Lorazepam	Lorazepam	72	16
Doxycycline Hyclate	Doxycycline Hyclate	69	59
Prednisone	Prednisone	68	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	67	17
Azithromycin	Azithromycin	63	54
Clopidogrel	Clopidogrel Bisulfate	63	19
Ozempic	Semaglutide	63	12
Fluoxetine Hcl	Fluoxetine Hcl	60	15
Carvedilol	Carvedilol	58	14
Trazodone Hcl	Trazodone Hcl	58	suppressed
Famotidine	Famotidine	56	16
Synthroid	Levothyroxine Sodium	43	11
Paroxetine Hcl	Paroxetine Hcl	42	11
Ezetimibe	Ezetimibe	41	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	12
Glimepiride	Glimepiride	40	11
Carisoprodol	Carisoprodol	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	14
Spironolactone	Spironolactone	39	13
Glipizide	Glipizide	37	suppressed
Ramipril	Ramipril	35	suppressed
Estradiol	Estradiol	34	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Bumetanide	Bumetanide	33	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	29
Triamcinolone Acetonide	Triamcinolone Acetonide	33	23
Cephalexin	Cephalexin	32	27
Diazepam	Diazepam	32	11
Montelukast Sodium	Montelukast Sodium	32	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	32	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Colestipol Hcl	Colestipol Hcl	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Nystatin	Nystatin	29	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Naproxen	Naproxen	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	15
Lidocaine	Lidocaine	25	13
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	13
Mounjaro	Tirzepatide	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	16
Xarelto	Rivaroxaban	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	15
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Finasteride	Finasteride	20	suppressed
Fluconazole	Fluconazole	20	14
Lansoprazole	Lansoprazole	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Temazepam	Temazepam	19	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Hydrocortisone	Hydrocortisone	17	16
Labetalol Hcl	Labetalol Hcl	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Torsemide	Torsemide	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Baclofen	Baclofen	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Ursodiol	Ursodiol	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	13	13
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Naloxone Hcl	Naloxone Hcl	13	13
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Digoxin	Digoxin	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sucralfate	Sucralfate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Klayesta	Nystatin	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error